Skip to main content

Peer Review reports

From: Development of a novel immune-related lncRNA prognostic signature for patients with hepatocellular carcinoma

Original Submission
6 Jun 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
22 Jul 2022 Reviewed Reviewer Report
24 Jul 2022 Reviewed Reviewer Report
8 Aug 2022 Author responded Author comments - Huihua Xiong
Resubmission - Version 4
8 Aug 2022 Submitted Manuscript version 4
18 Aug 2022 Author responded Author comments - Huihua Xiong
Resubmission - Version 5
18 Aug 2022 Submitted Manuscript version 5
19 Aug 2022 Author responded Author comments - Huihua Xiong
Resubmission - Version 6
19 Aug 2022 Submitted Manuscript version 6
24 Aug 2022 Reviewed Reviewer Report
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
14 Oct 2022 Editorially accepted
7 Nov 2022 Article published 10.1186/s12876-022-02540-2

You can find further information about peer review here.

Back to article page